Charles Schwab’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
1,086,175
+19,871
| +2% | +$54.2K | ﹤0.01% | 2552 |
|
|
2025
Q1 | $1.79M | Buy |
1,066,304
+9,792
| +0.9% | +$16.5K | ﹤0.01% | 2650 |
|
|
2024
Q4 | $1.72M | Buy |
1,056,512
+8,666
| +0.8% | +$14.1K | ﹤0.01% | 2725 |
|
|
2024
Q3 | $4.36M | Buy |
1,047,846
+105,382
| +11% | +$438K | ﹤0.01% | 2443 |
|
|
2024
Q2 | $5.15M | Buy |
942,464
+118,954
| +14% | +$649K | ﹤0.01% | 2347 |
|
|
2024
Q1 | $8.24M | Buy |
823,510
+74,675
| +10% | +$747K | ﹤0.01% | 2078 |
|
|
2023
Q4 | $3.06M | Buy |
748,835
+17,519
| +2% | +$71.5K | ﹤0.01% | 2502 |
|
|
2023
Q3 | $2.83M | Buy |
731,316
+56,197
| +8% | +$217K | ﹤0.01% | 2493 |
|
|
2023
Q2 | $4.02M | Buy |
675,119
+104,299
| +18% | +$622K | ﹤0.01% | 2323 |
|
|
2023
Q1 | $1.87M | Sell |
570,820
-80,980
| -12% | -$265K | ﹤0.01% | 2541 |
|
|
2022
Q4 | $2.57M | Buy |
651,800
+16,931
| +3% | +$66.9K | ﹤0.01% | 2487 |
|
|
2022
Q3 | $3.81M | Buy |
634,869
+35,244
| +6% | +$212K | ﹤0.01% | 2363 |
|
|
2022
Q2 | $3.86M | Sell |
599,625
-12,428
| -2% | -$79.9K | ﹤0.01% | 2302 |
|
|
2022
Q1 | $5.06M | Buy |
612,053
+17,340
| +3% | +$143K | ﹤0.01% | 2274 |
|
|
2021
Q4 | $9.21M | Buy |
594,713
+11,916
| +2% | +$184K | ﹤0.01% | 2045 |
|
|
2021
Q3 | $13.1M | Buy |
582,797
+355,387
| +156% | +$8M | ﹤0.01% | 1853 |
|
|
2021
Q2 | $4.47M | Buy |
227,410
+58,914
| +35% | +$1.16M | ﹤0.01% | 2405 |
|
|
2021
Q1 | $5.64M | Buy |
+168,496
| New | +$5.64M | ﹤0.01% | 2237 |
|